C57BL/6 mice were bred in a pathogen-free environment at the Institute for Animal Experimentation, Tohoku University Graduate School

of Medicine. All mice were used for experiments at 6–8 weeks of age. All experimental protocols described in the present study were approved by the Ethics selleck chemicals llc Review Committee for Animal Experimentation of our university. A serotype 3, clinical strain of S. pneumoniae, designated as URF918, was established from a patient with pneumococcal pneumonia (Kawakami et al., 2003). The bacteria were cultured in Todd–Hewitt broth (Difco, Detroit, MI) at 37 °C in a 5% CO2 incubator, harvested at 6 h, at the midlog phase of growth, and then washed twice in phosphate-buffered Tamoxifen cell line saline (PBS). The inoculum was prepared at 4–6 × 107 CFU mL−1. To induce pulmonary infection, mice were anesthetized by an intraperitoneal injection of 70 mg kg−1 of pentobarbital (Abbott Lab., North Chicago, IL) and restrained on a small board. Live S.

pneumoniae were inoculated at 50 μL per mouse by insertion of a 24-G blunt needle into and parallel to the trachea. In every experiment, a quantification culture was performed to confirm the inoculation dose. Mice were sacrificed before or at various time intervals after infection and samples of BALFs were collected as described below. Briefly, after bleeding under anesthesia with ether, the chest was opened and the trachea was cannulated with the outer sheath of a 22 G intravenous catheter/needle unit (Terumo, Tokyo, Japan), followed by lavage of the lung three times with 1 mL of chilled PBS. The obtained BALFs were centrifuged at 450 g for 5 min. The cell pellets were analyzed for the fractions of leukocytes and the expression of surface antigens and intracellular TNF-α, and the supernatants were kept at −80 °C until measurement of cytokines. Axenfeld syndrome Approximately 1 × 105 BALF cells were centrifuged onto a glass slide at 110 g for 3 min using an Auto Smear CF-12D (Sakura Co., Tokyo), stained by May–Giemsa or Diff-Quick (Sysmex,

Kobe, Japan) and observed under a microscope. The number of leukocyte fractions was estimated by multiplying the total leukocyte number by the proportion of each fraction in 500–1000 cells. The BALF cells were preincubated with anti-FcγRII and III mAb, prepared by a protein G column kit (Kirkegaard & Perry Laboratories, Gaithersburg, MD) from the culture supernatants of hybridoma cells (clone 2.4G2), on ice for 15 min in PBS containing 1% fetal calf serum (FCS) (Cansera, Rexdale, ON, Canada) and 0.1% sodium azide, and stained with phycoerythrin (PE)-conjugated anti-F4/80 or Gr-1 mAb (clone BM8 or RB6-8C5; BD Biosciences, San Jose, CA, or e-Bioscience, San Diego, CA, respectively).